Trial Profile
A Phase 1, Double Blind (Sponsor Open), Randomized, Placebo Controlled, Parallel Group, Oral Multiple Dose Trial To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF 03882845 In Healthy Volunteers.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs PF 3882845 (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions; Pharmacokinetics
- 24 Dec 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 24 Dec 2009 Actual patient number (10) added as reported by ClinicalTrials.gov.
- 05 May 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.